iifl-logo

Fredun Pharmaceuticals Ltd Share Price Live

₹1,190.6
(1.19%)
Sep 2, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open₹1,179
  • Day's High₹1,225
  • 52 Wk High₹1,329
  • Prev. Close₹1,176.6
  • Day's Low₹1,151
  • 52 Wk Low ₹635
  • Turnover (lac)113.01
  • P/E23.98
  • Face Value₹10
  • Book Value₹299.47
  • EPS49.65
  • Mkt. Cap (Cr.)₹562.16
  • Div. Yield0.06
View All Historical Data

No Record Found

Loading...

Fredun Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹1,179

Prev. Close

₹1,176.6

Turnover(Lac.)

₹113.01

Day's High

₹1,225

Day's Low

₹1,151

52 Week's High

₹1,329

52 Week's Low

₹635

Book Value

₹299.47

Face Value

₹10

Mkt Cap (₹ Cr.)

562.16

P/E

23.98

EPS

49.65

Divi. Yield

0.06

Fredun Pharmaceuticals Ltd Corporate Action

7 May 2024

12:00 AM

Dividend

Dividend Amount: 0.7

Record Date: 23 Sep, 2024

arrow

18 Sep 2024

12:00 AM

AGM

Announcement Date: 18 Sep, 2024

arrow

14 Jul 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Fredun Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

Fredun Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

02 Sep, 2025|01:41 AM
Jun-2025Mar-2025Dec-2024Sep-2024
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 48.93%

Foreign: 0.00%

Indian: 48.93%

Non-Promoter- 1.58%

Institutions: 1.58%

Non-Institutions: 49.48%

Custodian: 0.00%

Read More
Share Price

Fredun Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

6.27

12.86

4.64

3.99

Preference Capital

0

0

0

0

Reserves

115.2

83.52

63.42

39.08

Net Worth

121.47

96.38

68.06

43.07

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

133.89

112.77

58.06

56.69

yoy growth (%)

18.72

94.2

2.41

33.96

Raw materials

-101.77

-80.14

-39.51

-37.17

As % of sales

76

71.06

68.04

65.57

Employee costs

-8.65

-8.94

-5.18

-4.91

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

4.37

2.49

2.64

2.22

Depreciation

-2

-1.87

-1.28

-1.13

Tax paid

-1.19

-0.59

-0.89

-0.79

Working capital

7.41

38.35

2.4

0.25

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

18.72

94.2

2.41

33.96

Op profit growth

10.51

95.94

27.02

-14.89

EBIT growth

23.5

50.86

11.66

3.5

Net profit growth

5.92

8.62

22.66

33.46

View Ratios
Particulars (Rupees in Crores.)Mar-2025

Gross Sales

451.71

Excise Duty

0

Net Sales

451.71

Other Operating Income

4.56

Other Income

0

Fredun Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,563.35

75.313,75,100.03753.531.025,566.68101.44

Divis Laboratories Ltd

DIVISLAB

6,091.05

69.221,61,698.245570.492,357561.08

Cipla Ltd

CIPLA

1,587.6

24.821,28,239.041,303.131.014,501.66397.38

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,581.55

60.971,21,210.485510.172,567224.34

Dr Reddys Laboratories Ltd

DRREDDY

1,280.3

15.51,06,852.042,961.20.627,788.7345.76

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Fredun Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairperson & Joint MD

Daulat N Medhora

Non Executive Director

Nariman B Medhora

Non Executive & Independent Director

Aspi N Raimalwala

Managing Director & CFO

Fredun N Medhora

Non Executive & Independent Director

Rohinton Kanga

Non Executive & Independent Director

Daisy Dsouza

Independent Director

Anshu Agarwal

Independent Director

Sonal Desai

Registered Office

26 Manoj Industrial Premises,

G D Ambedkar Marg Wadala,

Maharashtra - 400031

Tel: 91-22-40318111

Website: http://www.fredungroup.com

Email: business@fredungroup.com

Registrar Office

9 ShivShakti Indl Es,

J R Boricha Marg, Lower Parel,

Mumbai - 400 011

Tel: 91-22-23016761/8261

Website: -

Email: -

Summary

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.94. The Company was promoted by Nariman Medhora and Daulat N Medhora....
Read More

Reports by Fredun Pharmaceuticals Ltd

Company FAQs

What is the Fredun Pharmaceuticals Ltd share price today?

The Fredun Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹1190.6 today.

What is the Market Cap of Fredun Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fredun Pharmaceuticals Ltd is ₹562.16 Cr. as of 02 Sep ‘25

What is the PE and PB ratio of Fredun Pharmaceuticals Ltd?

The PE and PB ratios of Fredun Pharmaceuticals Ltd is 23.98 and 3.98 as of 02 Sep ‘25

What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Fredun Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Fredun Pharmaceuticals Ltd is ₹635 and ₹1329 as of 02 Sep ‘25

What is the CAGR of Fredun Pharmaceuticals Ltd?

Fredun Pharmaceuticals Ltd's CAGR for 5 Years at 41.15%, 3 Years at -1.13%, 1 Year at 43.81%, 6 Month at 73.02%, 3 Month at 65.22% and 1 Month at 16.86%.

What is the shareholding pattern of Fredun Pharmaceuticals Ltd?

The shareholding pattern of Fredun Pharmaceuticals Ltd is as follows:
Promoters - 48.93 %
Institutions - 1.59 %
Public - 49.48 %

QUICKLINKS FOR Fredun Pharmaceuticals Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.